BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 138.19 Million USD | -15.48% |
| 2022 | 163.51 Million USD | 2.62% |
| 2021 | 159.34 Million USD | 63.04% |
| 2020 | 97.73 Million USD | 304.79% |
| 2019 | 24.14 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 106.57 Million USD | -9.3% |
| 2024 Q2 | 1.19 Billion SEK | -9.76% |
| 2024 Q1 | 124.09 Million SEK | -5.11% |
| 2023 Q4 | 138.19 Million USD | 2.18% |
| 2023 FY | 138.19 Million USD | -15.48% |
| 2023 Q3 | 135.25 Million USD | -8.34% |
| 2023 Q2 | 147.56 Million USD | -7.11% |
| 2023 Q1 | 158.85 Million USD | -2.85% |
| 2022 Q2 | 151.62 Million USD | 0.0% |
| 2022 FY | 163.51 Million USD | 2.62% |
| 2022 Q4 | 163.51 Million USD | 3.41% |
| 2022 Q3 | 158.12 Million USD | 4.29% |
| 2021 FY | 159.34 Million USD | 63.04% |
| 2020 FY | 97.73 Million USD | 304.79% |
| 2019 FY | 24.15 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -36060.671% |
| CSL Limited | 38.02 Billion USD | 99.637% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -255.749% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -1814.16% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -180896.105% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -1209.435% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -6.134% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -190873.214% |
| Mesoblast Limited | 667.9 Million USD | 79.309% |
| Marizyme, Inc. | 22.01 Million USD | -527.742% |
| Genus plc | 1.02 Billion USD | 86.568% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -10073.921% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -27592.779% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -21941.111% |
| ContraFect Corporation | 20.67 Million USD | -568.3% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -35302.101% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 31.33 Million USD | -341.05% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -3233.262% |
| MultiCell Technologies, Inc. | 126.22 USD | -109489494.359% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -14606.756% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -7.539% |
| EV Biologics, Inc. | 431.71 Thousand USD | -31911.416% |
| Q BioMed Inc. | 3.51 Million USD | -3831.079% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -292.842% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -52793.2% |
| Biomind Labs Inc. | 73.81 Thousand USD | -187111.647% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -360.43% |
| Skye Bioscience, Inc. | 11.94 Million USD | -1057.395% |
| SQZ Biotechnologies Company | 107.18 Million USD | -28.931% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -4932.08% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -6957.427% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -9550.466% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -20001.903% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -17832.764% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | 70.142% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -4071.363% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -5208.773% |
| GB Sciences, Inc. | 103.44 Thousand USD | -133499.279% |
| Alpha Cognition Inc. | 2.45 Million USD | -5535.733% |
| argenx SE | 4.54 Billion USD | 96.958% |
| HST Global, Inc. | 1526.00 USD | -9056110.092% |
| Halberd Corporation | 10.13 Thousand USD | -1364007.847% |
| Enzolytics Inc. | 361.7 Million USD | 61.793% |
| Resverlogix Corp. | 8.11 Million USD | -1602.992% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -7259.244% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -394.553% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 69.035% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -189.711% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -9438.491% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -21505.014% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -606536.083% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -1444.255% |
| AVAX Technologies, Inc. | 7.37 Million USD | -1773.32% |
| ONE Bio Corp. | 70.08 Million USD | -97.185% |
| Zenith Capital Corp. | 7410.00 USD | -1864917.085% |
| Genscript Biotech Corporation | 3.38 Billion USD | 95.919% |
| Ember Therapeutics, Inc. | 184.00 USD | -75107381.522% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -42844.434% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -52775.593% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -14792.627% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -13888.095% |
| Agentix Corp. | 261.39 Thousand USD | -52769.929% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 2.3 Million USD | -5897.959% |
| Helix BioMedix, Inc. | 3.02 Million USD | -4468.391% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -162.23% |
| BioStem Technologies, Inc. | 14.56 Million USD | -849.142% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -241953.046% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -5982487.273% |
| LadRx Corporation | 2.3 Million USD | -5888.078% |
| Cell Source, Inc. | 195.17 Thousand USD | -70708.556% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -28657.83% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -38981.2% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -38981.2% |
| NovAccess Global Inc. | 62.24 Thousand USD | -221911.576% |
| Affymax, Inc. | 7.44 Million USD | -1756.748% |
| Itoco Inc. | 1.4 Million USD | -9770.761% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -144372.193% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -130275.251% |
| CytoDyn Inc. | 11.13 Million USD | -1141.0% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -96560.721% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -772818.154% |
| Qrons Inc. | 420.00 USD | -32904130.0% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -35751.664% |
| SYBLEU INC | 330.46 Thousand USD | -41718.804% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -24930.386% |
| Rebus Holdings, Inc. | 5000.00 USD | -2763855.32% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -33654.358% |
| Mobile Lads Corp. | 52.00 USD | -265764834.615% |
| International Stem Cell Corporation | 5.39 Million USD | -2463.966% |
| Bioxytran, Inc. | 137.63 Thousand USD | -100306.694% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -821.206% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -733.571% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -174833.881% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -15882.588% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -1738.47% |
| Neutra Corp. | 2851.00 USD | -4847243.599% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -326.457% |
| PureTech Health plc | 693.97 Million USD | 80.086% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -1612.257% |
| IXICO plc | 15.84 Million USD | -772.246% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -1568.652% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -33.752% |
| CSL Limited | 38.02 Billion USD | 99.637% |
| Cellectis S.A. | 333.99 Million USD | 58.623% |